A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
Hoffmann-La Roche
Stanford University
Novartis
TaiHao Medical Inc.
University of Illinois at Chicago
Envision Healthcare Scientific Intelligence, Inc.
Mayo Clinic
Novartis
University of Kansas Medical Center
Merck Sharp & Dohme LLC